hcp.obgyn.net Members: Login | Register
OBGYN.net Recommended Medical Sites Medline Drugs

Powered by SearchMedica

 
  • Home
  • News
  • Blogs
  • Calendar
  • Conditions and Procedures
  • Conferences
  • Tutorials
  • Forum
  • Ultrasound
  • Buyer's Guide
Home » Conferences

OBGYN.net.
SMFM 2007 

Challenging the TH1/TH2 Paradigm of Pregnancy

By Donna Neale1, Irene Visintin2, Vikki Abrahams3, Gil Mor4
1 Johns Hopkins University, Baltimore, Maryland
2 Yale University, New Haven, Connecticut
3 Yale University, Obstetrics & Gynecology, New Haven, Connecticut
4 Yale University, Obstetrics and Gynecology, New Haven, Connecticut | September 12, 2007

view the interview video: Challenging the TH1/TH2 Paradigm of Pregnancy

Abstract

Objective: There is a complement of cell types at the maternal-fetal interface, including, trophoblast, immune cells, decidual cells, and endothelial cells. The success of a pregnancy depends on how well the trophoblast responds/adapts to this environment. Mediators between these cell types include cytokines, growth factors and chemokines. We hypothesize that each trimester of a normal pregnancy is characterized by a unique and specific cytokine, chemokine and growth factor profile. This profile represents the process of adaptation of the mother to the presence of the fetus as well as the fetus to the maternal signals. Therefore, alterations in this process could be identified in the peripheral blood of the mother. Our objective was to establish a trimester specific protein profile.

Study Design: We obtained 1st, 2nd and 3rd trimester serum samples from women who completed a normal pregnancy. Using a cytokine micro array, we screened these samples for 60 proteins. Results from the cytokine micro arrays were validated using ELISA and Luminex.

Results: Trimester specific predominant protein profiles were as follows: 1st trimester - pro imflammatory, 2nd trimester - anti inflammatory and 3rd trimester - pro inflammatory.

Conclusion: These results challenge the TH1/TH2 paradigm of pregnancy, as a switch to a predominate TH2 environment did not occur until the 2nd trimester. Furthermore, this switch was not permanent as the 3rd trimester serum samples showed a pro inflammatory profile. We believe that the pro inflammatory protein profile seen in the 1st trimester serums is necessary for implantation/placentation while the pro inflammatory profile seen in the 3rd trimester samples is necessary for the initiation of labor. Thus, it may be too simplistic to regard pregnancy as a pure switch to a TH2 immunological environment. Instead, our findings suggest that normal pregnancy is a balance and interplay between TH1 and TH2 activity.


 

Join the Conversation

Want to join the conversation? Just sign in or register today to become part of our growing, online community.





0002-9378/$ - see front matter
doi:10.1016/j.ajog.2006.10.562
American Journal of Obstetrics and Gynecology
Volume 195, Issue 6, Supplement S (December 2006)

TopicIndex

 

Adhesions
Breast Health and Breast Care
Contraception
Electronic Health Records (EHRs)
Endometriosis
Fetal Monitoring
Fibroids
Gestational Diabetes
Gynecologic Oncology
Hysterectomy
Infertility
In Vitro Fertilization (IVF)
Laparoscopy
Malpractice

  Menopause
Osteoporosis

Polycystic Ovary Syndrome
Postpartum Depression
Pelvic Pain
Premenstrual Syndrome/Premenstrual Dysphoric Disorder (PMS/PMDD)
Pregnancy and Birth
Sex-related Issues
Ultrasound
Urogynecology
Uterine (Endometrial) Polyps
Weight Management
Young Women

 

MedicalProfessionalForum


Educational Tutorials

Update on Amniotic Fluid Embolism, Professor Rifaat Al-Shimmy

 

 

 

Disseminated Intravascular Coagulation, Professor Rifaat Al-Shimmy

Submit Your Tutorial

 

  • On This Site
  • Most Emailed
  • On This Topic

MostPopular

  • DailyDx: 3D Images of a 14-week fetus

    APR 16 2013 OBGYN.NET READ >>

  • DailyDx: A 12-Week Fetus

    APR 23 2013 OBGYN.NET READ >>

  • 6 Ways Ob/Gyns Can Use Social Media

    AUG 2 2012 OBGYN.NET READ >>

  • The Relationship Between Placental Location and Fetal Gender (Ramzi’s Method)

    JUN 14 2011 OBGYN.NET READ >>

  • Daily Dx: Young Lady with Abdominal Pain

    MAY 1 2013 OBGYN.NET READ >>

MostPopular

  • Surgery for Endometriosis Protects Against Ovarian Cancer

    APR 15 2013OBGYN.NET READ >>

  • Prophylactic Progesterone May Be Harmful in Twin Pregnancies

    MAY 8 2013OBGYN.NET READ >>

  • Early Surgically-Induced Menopause Linked with Cognitive Decline

    MAY 9 2013OBGYN.NET READ >>

  • Postsurgical Levonorgestrel IUD Improves Endometriosis Symptoms

    APR 24 2013OBGYN.NET READ >>

  • FDA Approves “Morning Sickness” Medication

    APR 17 2013OBGYN.NET READ >>

MostPopular

  • Postpartum Hemorrhage: a practical guide - M. El Sherbiny, MD

    AUG 17 2011 OBGYN.NET READ >>

  • Does Controlled Cord Traction Reduce Postpartum Blood Loss?

    MAY 10 2013 OBGYN.NET READ >>

  • Do Omega-3 Fatty Acids Prevent Depression in Pregnant Women?

    MAY 3 2013 OBGYN.NET READ >>

  • Bakri Balloon for Postpartum Hemorrhage: Does It Work?

    OCT 25 2011 OBGYN.NET READ >>

  • Postpartum Symptoms of PTSD Are Higher Than Expected

    SEP 24 2012 OBGYN.NET READ >>

Ultrasound Image Gallery and Case Studies

Retained Products of Conception - Paulo Pires Cegalla

 

 

 

Large Ovarian Cyst - Aniruddha Kulkarni, MD

Medical Professionals: Upload a Case or Image

 

EventCalendar

 

 

 

SearchMedicaSearchResult

Find peer-reviewed literature and websites for practicing medical professionals

CME on Conference Insider
Evidence on Conference Insider
Guidelines on Conference Insider
Patient Education on Conference Insider
Clinical Trials on Conference Insider
Practical Articles on Conference Insider
Research and Reviews on Conference Insider
All "Conference Insider" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy